TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Intensive Cognitive Rehabilitation in Subacute Stroke Patient
Brief Summary: Early stroke rehabilitation is known to be an effective and essential therapy in gaining functional independence and preventing complications. However, there was no consensus of proper amount of cognitive rehabilitation in stroke patients. In this study, the investigators assess the effects of the intensive cognitive rehabilitation during subacute phase to improve cognitive function at 6 months after onset in patients with first-ever strokes.


Options:
A: Arm Label: Exercise + practice; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise, Behavioral: Practice | Arm Label: Rest + practice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Practice | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise + practice | Intervention Type: BEHAVIORAL; Name: Practice; Assigned to Arm(s): Exercise + practice, Rest + practice
B: Arm Label: hemiplegic patient; Type: EXPERIMENTAL; Interventions: Device: transcranial Direct current stimulation | Arm Label: patient control; Type: SHAM_COMPARATOR; Interventions: Device: transcranial Direct current stimulation | Intervention Type: DEVICE; Name: transcranial Direct current stimulation; Assigned to Arm(s): hemiplegic patient, patient control
C: Arm Label: Stroke Management Program (SMP); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stroke Management Program (SMP) | Arm Label: Stroke Monitoring Program (SMonP); Type: EXPERIMENTAL; Interventions: Behavioral: Stroke Monitoring Program (SMonP) | Arm Label: Stroke Supplementary Program (SSP); Type: EXPERIMENTAL; Interventions: Behavioral: Stroke Supplementary Program (SSP) | Intervention Type: BEHAVIORAL; Name: Stroke Management Program (SMP); Assigned to Arm(s): Stroke Management Program (SMP) | Intervention Type: BEHAVIORAL; Name: Stroke Monitoring Program (SMonP); Assigned to Arm(s): Stroke Monitoring Program (SMonP) | Intervention Type: BEHAVIORAL; Name: Stroke Supplementary Program (SSP); Assigned to Arm(s): Stroke Supplementary Program (SSP)
D: Arm Label: Intensive group; Type: EXPERIMENTAL; Interventions: Procedure: Cognitive rehabilitation | Arm Label: Conventional group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cognitive rehabilitation | Intervention Type: PROCEDURE; Name: Cognitive rehabilitation; Assigned to Arm(s): Conventional group, Intensive group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Closed-loop Automatic Control of the Inspiratory Fraction of Oxygen (FiO2-C) on Outcome of Extremely Preterm Infants - a Randomized Controlled Parallel Group Multicenter Trial for Safety and Efficacy
Brief Summary: Extremely low gestational age neonates (ELGANs), i.e. those born at \<28 weeks, frequently experience intermittent hypoxemic/hyperoxemic episodes. Observational data indicate that severe and prolonged hypoxemic episodes are associated with retinopathy of prematurity (ROP), impaired long-term development and death. Closed-loop automated control of the inspiratory fraction of oxygen (FiO2-C) reduces time outside the oxygen target range, decreases number and duration of hypo- and hyperoxemic episodes, and reduces caregivers' workload. The proposed observer-blinded randomized controlled trial was designed and will be powered to compare the effect of FiO2-C in addition to manual adjustments, in comparison with manual adjustments of FiO2 only, on death and severe complications of prematurity thought to be related to hypoxia/hyperoxia and neurodevelopmental impairment in ELGANs. The results of this trial may help to improve the quality of life of ELGANs and reduce the burden of significant morbidity as well as costs for health care and society


Options:
A: Arm Label: Automatic Oxygen Control; Type: EXPERIMENTAL; Interventions: Device: Automatic Oxygen control | Arm Label: Manual oxygen control; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual Oxygen Control | Intervention Type: DEVICE; Name: Automatic Oxygen control; Assigned to Arm(s): Automatic Oxygen Control | Intervention Type: OTHER; Name: Manual Oxygen Control; Assigned to Arm(s): Manual oxygen control
B: Arm Label: IntellO2; Type: EXPERIMENTAL; Interventions: Device: IntellO2 | Arm Label: Manual; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual control | Intervention Type: DEVICE; Name: IntellO2; Assigned to Arm(s): IntellO2 | Intervention Type: OTHER; Name: Manual control; Assigned to Arm(s): Manual
C: Arm Label: Experimental: device FreeO.; Type: EXPERIMENTAL; Interventions: Device: FreeO2 v2.0 automatic adjustment | Arm Label: Manual oxygenation; Type: ACTIVE_COMPARATOR; Interventions: Device: FreeO2 v2.0 data collecting | Intervention Type: DEVICE; Name: FreeO2 v2.0 automatic adjustment; Assigned to Arm(s): Experimental: device FreeO. | Intervention Type: DEVICE; Name: FreeO2 v2.0 data collecting; Assigned to Arm(s): Manual oxygenation
D: Arm Label: Experimental intervention; Type: EXPERIMENTAL; Interventions: Device: closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) | Arm Label: Control intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C); Assigned to Arm(s): Experimental intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Sequential Imagery Rehearsal Therapy and Cognitive-Behavioural Therapy in Sexual Assault Victims With Posttraumatic Stress Disorder: a Randomized Control Trial
Brief Summary: Sexual assault victims (SAV) have an elevated risk of developing posttraumatic stress disorder (PTSD). Trauma-focused cognitive-behavioural therapy (CBT) is an effective first-line treatment for this pathology. However, although sleep disturbances are a common complaint in SAV with PTSD, trauma-focused CBT does not directly address this symptom. Posttraumatic nightmares are widespread among SAV. Trauma-related sleep disturbances are associated with significant impairment in general functioning and quality of life (mental and physical health), and contribute to the maintenance of PTSD symptoms. This study evaluates the efficacy of sequential nightmare therapy (imagery rehearsal therapy; IRT) and trauma-focused CBT, in comparison to CBT alone. Forty-two SAV suffering from PTSD and sleep difficulties were recruited and randomly assigned to the experimental (IRT+CBT) or control condition (waiting period followed by CBT alone). Participants were administered a clinical interview and a series of questionnaires assessing PTSD symptoms, general functioning and quality of life.


Options:
A: Arm Label: CBT-E; Type: EXPERIMENTAL; Interventions: Behavioral: Specific Modules, Behavioral: Cognitive behavioral therapy | Arm Label: CBT-C; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy | Intervention Type: BEHAVIORAL; Name: Specific Modules; Assigned to Arm(s): CBT-E | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy; Assigned to Arm(s): CBT-C, CBT-E
B: Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: MI with trauma-informed SGM affirmative care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Trauma-informed SGM affirmative care | Intervention Type: BEHAVIORAL; Name: Trauma-informed SGM affirmative care; Assigned to Arm(s): MI with trauma-informed SGM affirmative care | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Motivational Interviewing
C: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Prolonged Exposure (PE) Therapy | Intervention Type: BEHAVIORAL; Name: Prolonged Exposure (PE) Therapy; Assigned to Arm(s): 2
D: Arm Label: CBT for PTSD; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD | Arm Label: Imagery Rehearsal Therapy + CBT for PTSD; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD, Behavioral: Imagery Rehearsal Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for PTSD; Assigned to Arm(s): CBT for PTSD, Imagery Rehearsal Therapy + CBT for PTSD | Intervention Type: BEHAVIORAL; Name: Imagery Rehearsal Therapy; Assigned to Arm(s): Imagery Rehearsal Therapy + CBT for PTSD

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Brief Summary: Study Hypothesis: Preterm infants administered weekly Darbe during the neonatal period will have improved neurocognitive outcome at 22-26 months compared to placebo


Options:
A: Arm Label: Darbepoetin; Type: EXPERIMENTAL; Interventions: Drug: Darbepoetin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Darbepoetin; Assigned to Arm(s): Darbepoetin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Low Threshold Transfusion; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Restricted red cell transfusion | Arm Label: High Threshold Transfusion; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Liberal Cell Transfusion | Intervention Type: PROCEDURE; Name: Liberal Cell Transfusion; Assigned to Arm(s): High Threshold Transfusion | Intervention Type: PROCEDURE; Name: Restricted red cell transfusion; Assigned to Arm(s): Low Threshold Transfusion
C: Arm Label: "liberal" transfusion triggers; Type: EXPERIMENTAL; Interventions: Other: red blood cell transfusion | Arm Label: "restrictive" transfusion triggers; Type: ACTIVE_COMPARATOR; Interventions: Other: red blood cell transfusion | Intervention Type: OTHER; Name: red blood cell transfusion; Assigned to Arm(s): "liberal" transfusion triggers | Intervention Type: OTHER; Name: red blood cell transfusion; Assigned to Arm(s): "restrictive" transfusion triggers
D: Arm Label: Infant Blood; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Drawing admission labs from infant blood | Arm Label: Cord Blood; Type: EXPERIMENTAL; Interventions: Procedure: Drawing admission labs from cord blood | Intervention Type: PROCEDURE; Name: Drawing admission labs from cord blood; Assigned to Arm(s): Cord Blood | Intervention Type: PROCEDURE; Name: Drawing admission labs from infant blood; Assigned to Arm(s): Infant Blood

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients With Severe Asthma Uncontrolled on Standard of Care Treatment
Brief Summary: The purpose of this study is to investigate the effect of benralizumab on the rate of asthma exacerbations, patient reported quality of life and lung function during the 24-week treatment in patients with uncontrolled, severe asthma with an eosinophilic phenotype. A subset of patients will be assessed for their ongoing chronic rhinosinusitis with nasal polyps. The study design has been updated to include a 56-week open label ANDHI in Practice (ANDHI IP) sub study upon the completion of the 24-week double-blind period of the ANDHI study.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Reslizumab - 0.3 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: Reslizumab | Arm Label: Reslizumab - 3.0 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: Reslizumab | Intervention Type: DRUG; Name: Reslizumab; Assigned to Arm(s): Reslizumab - 0.3 mg/kg, Reslizumab - 3.0 mg/kg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Benralizumab 30 mg q.4 weeks; Type: EXPERIMENTAL; Interventions: Biological: Benralizumab | Arm Label: Benralizumab 30 mg q.8 weeks; Type: EXPERIMENTAL; Interventions: Biological: Benralizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Benralizumab; Assigned to Arm(s): Benralizumab 30 mg q.4 weeks, Benralizumab 30 mg q.8 weeks | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: huMAb OX40L; Type: EXPERIMENTAL; Interventions: Drug: huMAb OX40L | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: huMAb OX40L; Assigned to Arm(s): huMAb OX40L | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
D: Arm Label: Benralizumab (Medi-563); Type: EXPERIMENTAL; Interventions: Drug: Benralizumab (Medi-563) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Benralizumab (Medi-563); Assigned to Arm(s): Benralizumab (Medi-563) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Developmental Screening and Nutritional Intervention of Severe Acute Malnourished Children in Southern Punjab, Pakistan
Brief Summary: i. To examine the impact of malnutrition on development quotient of children

ii. To determine the effectiveness of Ready to Use Therapeutic Food (RUTF) in improving the development quotient of severe acute malnourished children under five year of age.

iii. To investigate the outcome of Vitamin D therapeutic doses intervention with RUTF rehabilitation on growth and development of malnourished children.


Options:
A: Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D2; Assigned to Arm(s): N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): N/A
B: Arm Label: Vitamin D + Calcium; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D + Calcium | Arm Label: Calcium; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Calcium | Arm Label: Vitamin D2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D2 | Arm Label: Vitamin D3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D + Calcium; Assigned to Arm(s): Vitamin D + Calcium | Intervention Type: DIETARY_SUPPLEMENT; Name: Calcium; Assigned to Arm(s): Calcium | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D2; Assigned to Arm(s): Vitamin D2 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D3
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: cholecalciferol (vitamin D) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol (vitamin D); Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): 2
D: Arm Label: RUTF with Vitamin D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D, Dietary Supplement: Ready to Use Therapeutic Food (RUTF) | Arm Label: RUTF with Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Ready to Use Therapeutic Food (RUTF) | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): RUTF with Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: Ready to Use Therapeutic Food (RUTF); Assigned to Arm(s): RUTF with Placebo, RUTF with Vitamin D

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD
Brief Summary: This is a randomized, double-blind, parallel group, placebo-controlled, dose optimized, phase 3 study to evaluate the safety and efficacy of PRC-063 in the treatment of ADHD in pediatric subjects between 6 to 12 years of age.


Options:
A: Arm Label: Active Treatment; Type: EXPERIMENTAL; Interventions: Drug: PRC-063 oral capsules | Arm Label: Placebo Treatment; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo oral capsules | Intervention Type: DRUG; Name: PRC-063 oral capsules; Assigned to Arm(s): Active Treatment | Intervention Type: DRUG; Name: Placebo oral capsules; Assigned to Arm(s): Placebo Treatment
B: Arm Label: Active; Type: EXPERIMENTAL; Interventions: Drug: Quillivant Oral Suspension XR, Drug: Placebo | Arm Label: Comparator; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Quillivant Oral Suspension XR; Assigned to Arm(s): Active | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Active | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Comparator
C: Arm Label: Midazolam; Type: EXPERIMENTAL; Interventions: Drug: Midazolam | Arm Label: Isotonic saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Isotonic saline | Arm Label: Fentanyl; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fentanyl | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Midazolam | Intervention Type: DRUG; Name: Fentanyl; Assigned to Arm(s): Fentanyl | Intervention Type: DRUG; Name: Isotonic saline; Assigned to Arm(s): Isotonic saline
D: Intervention Type: DRUG; Name: Divalproex Sodium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Methylphenidate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Dextroamphetamine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Mixed Amphetamine Salts; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Family Counseling; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Behavior Management Training with Parents; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An RCT Evaluating the Implantation Potential of Vitrified Embryos Screened by Next Generation Sequencing Following Trophectoderm Biopsy, Versus Vitrified Unscreened Embryos in Good Prognosis Patients Undergoing IVF
Brief Summary: This is a two-arm parallel group randomized controlled trial at the Department of Reproductive Medicine at Ghent University Hospital. Women \>=18 and \<37 years of age undergoing their first or second IVF/ICSI treatment, with at least 2 good quality blastocysts remaining after fresh embryo transfer will be randomized to either transfer of a cryopreserved blastocyst selected based on morphology (standard treatment arm) or transfer of a cryopreserved blastocyst selected based on PGS and morphology (intervention treatment arm).


Options:
A: Arm Label: Comprehensive Chromosome Screening; Type: EXPERIMENTAL; Interventions: Other: Comprehensive Chromosome Screening | Arm Label: No Comprehensive Chromosome Screening; Type: PLACEBO_COMPARATOR; Interventions: Other: Morphologically Best | Intervention Type: OTHER; Name: Comprehensive Chromosome Screening; Assigned to Arm(s): Comprehensive Chromosome Screening | Intervention Type: OTHER; Name: Morphologically Best; Assigned to Arm(s): No Comprehensive Chromosome Screening
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Other: PGS | Arm Label: Group B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: PGS; Assigned to Arm(s): Group A
C: Arm Label: PGS (genetic screening); Type: EXPERIMENTAL; Interventions: Diagnostic Test: Preimplantation Genetic Screening | Arm Label: no PGS (no genetic screening); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIAGNOSTIC_TEST; Name: Preimplantation Genetic Screening; Assigned to Arm(s): PGS (genetic screening)
D: Arm Label: With PGS; Type: EXPERIMENTAL; Interventions: Procedure: IVF/ICSI, Genetic: PGS | Arm Label: Without PGS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: IVF/ICSI, Other: Without PGS | Intervention Type: PROCEDURE; Name: IVF/ICSI; Assigned to Arm(s): With PGS, Without PGS | Intervention Type: GENETIC; Name: PGS; Assigned to Arm(s): With PGS | Intervention Type: OTHER; Name: Without PGS; Assigned to Arm(s): Without PGS

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Handling Oxygenation Targets in Adults With Acute Hypoxaemic Respiratory Failure in the Intensive Care Unit: A Randomised Clinical Trial of a Lower Versus a Higher Oxygenation Target
Brief Summary: Handling oxygenation targets (HOT) is standard of care in the intensive care unit (ICU), however the quality and quantity of evidence is low and potential harm has been reported. The aim of the HOT-ICU trial is to assess the overall benefits and harms of two levels of oxygenation targets in adult critically ill patients with acute hypoxaemic respiratory failure in the ICU.


Options:
A: Arm Label: Liberal oxygen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Liberal Oxygen | Arm Label: Titrated oxygen; Type: EXPERIMENTAL; Interventions: Drug: Titrated Oxygen | Intervention Type: DRUG; Name: Titrated Oxygen; Assigned to Arm(s): Titrated oxygen | Intervention Type: DRUG; Name: Liberal Oxygen; Assigned to Arm(s): Liberal oxygen
B: Arm Label: High-normal PaO2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Arm Label: Low-normal PaO2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): High-normal PaO2, Low-normal PaO2
C: Arm Label: Low oxygenation target; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: High oxygenation target; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Low oxygenation target | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): High oxygenation target
D: Arm Label: 10 L O2/min; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: Room air; Type: SHAM_COMPARATOR; Interventions: Device: Room air | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): 10 L O2/min | Intervention Type: DEVICE; Name: Room air; Assigned to Arm(s): Room air

Answer: C